Skip to content

Study · Non-randomized trial · n = 33 · 1992

2 results

Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment.

Vercellini P, Vendola N, Bocciolone L, Colombo A, Rognoni MT, Bolis G

The Journal of reproductive medicine1 Jul 1992Cited by 40 (Europe PMC)

PMID1387905 (opens in a new tab)PepBankPUB-01387905
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In women after endometrioma aspiration, mean cyst diameter did not significantly differ between goserelin and observation at any observation time.

    In plain wordsIn women after cyst aspiration, mean cyst diameter did not significantly differ between goserelin and observation.

    Peptide
    Goserelin
    Outcome
    No significant changeEndometrioma diameter between groups
    Study

    n = 33

    Comparator
    Observation after aspiration
    Outcome group
    Organ injury · Reproductive and sexual health
    Studied dose
    Dose not stated · subcutaneous · 3 monthsAs given in this study (human).

    Source sentences

    Summary
    There were no significant differences in mean endometrioma diameter between the two groups at any observation time nor between prelaparoscopic and six-month ultrasound examinations within each treatment group.
    2 context sentences
    Summary · context
    this prospective study of 33 women with moderate or severe endometriosis who underwent laparoscopy for infertility and/or chronic pelvic pain,
    Summary · context
    After laparoscopy, 15 subjects received goserelin administered as a 28-day subcutaneous depot for three months, whereas 18 patients undergoing simple observation constituted internal controls.
  2. 02HumanNon-randomized trialEfficacy outcome

    After endometrioma aspiration, one goserelin-treated woman and three observation controls requested surgery between the four- and five-month scans.

    In plain wordsAfter cyst aspiration, one goserelin-treated woman and three observation controls requested surgery between the four- and five-month scans.

    Peptide
    Goserelin
    Outcome
    Not applicableSurgery during follow-up
    Study

    n = 33

    Comparator
    Observation after aspiration
    Outcome group
    Surgical outcomes · Reproductive and sexual health
    Studied dose
    Dose not stated

    Measurements

    Women requesting surgery
    1 woman
    goserelin
    Women requesting surgery
    3 women
    observation

    Source sentences

    Summary
    One case and three controls requested surgery between the four- and five-month follow-up scans and did not complete the study.
    1 context sentence
    Summary · context
    After laparoscopy, 15 subjects received goserelin administered as a 28-day subcutaneous depot for three months, whereas 18 patients undergoing simple observation constituted internal controls.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.